Skip to content

Clinical application and mechanism research of noninvasive positive pressure ventilation in promoting lung repair after ARDS

Clinical application and mechanism research of noninvasive positive pressure ventilation in promoting lung repair after ARDS

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021979
Enrollment
Unknown
Registered
2019-03-19
Start date
2019-03-25
Completion date
Unknown
Last updated
2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Distress Syndrome

Interventions

Routine group:Regular oxygen inhalation
Low pressure group:Noninvasive ventilation
High pressure group:Noninvasive ventilation

Sponsors

First Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Aged older than 18 yearsand younger than 65 years. (2) It conforms to the diagnostic criteria of ARDS defined in Berlin. (3) Respiratory failure due to ARDS requires mechanical ventilation for more than 72 hours. (4) 200 < P/F < 300 mmHg before evacuation of invasive ventilation.

Exclusion criteria

Exclusion criteria: (1) Barotrauma without effective drainage (pneumothorax, mediastinal emphysema, subcutaneous emphysema). (2) Pulmonary underlying diseases (COPD, pulmonary interstitial fibrosis, bronchiectasis, asthma, etc.). (3) Hemodynamic instability (norepinephrine > 0.1ug/kg/min or other vasoactive drugs of the same level). (4) There are definite neuromuscular diseases. (5) Head and face deformity can not cooperate with nasal/mask ventilation. (6) Severe abdominal distension or recent gastrointestinal surgery did not recover. (7) There are many airway secretions and poor airway protection ability. (8) Non-cooperation, can not cooperate with non-invasive ventilation. (9) There are pathologically confirmed malignant tumors. (10) Pregnant women.

Design outcomes

Primary

MeasureTime frame
Failure rate of treatment within 7 days;

Countries

China

Contacts

Public ContactXu Yonghao

Department of Critical Care Medicine, First Affiliated Hospital of Guangzhou Medical University

dryonghao@163.com+86 13828409707

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026